Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
To survive and support that, manufacturers will need to innovate and adapt quickly to not only more users but a much wider demographic.
We also report that 13% of patients with type 1 diabetes in our registry use adjuvant glucose-lowering therapy in addition to insulin, significantly higher than the 5.4% reported from the T1D Exchange Registry in the US [18]
Melbourne, Australia: Australian Securities Exchange (ASX (2007)
(PubMed) Keith DJ, Butler JA, Bemer B, et al
2024;47(Suppl 1):S1-S321
Celli, J
US$ 23.70
US$ 25.65
US$ 25.22
US$ 29.76
